Molecular mechanism of therapeutic approaches for human gastric cancer stem cells

doi:10.4252/wjsc.v14.i1.76

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5384)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

303

WORD

149

HTML

2759

Figures (1-3)

246

Tables (1-3)

233

Sum=3690

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

268

Download

576

Sum=844

Publishing Process of This Article

Item

Count

Browse

229

Download

621

Sum=850

Jan 26, 2022 (publication date) through Jul 18, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. Jan 26, 2022; 14(1): 76-91
Published online Jan 26, 2022. doi: 10.4252/wjsc.v14.i1.76

Table 3 Regulators of gastric cancer stem cells-related pathway stimuli in gastric cancer stem cells stemless properties and gastric cancer stem cells-targeted therapy

GCSCs pathway	Involved pathway proteins	Therapeutic inhibitor or drug	Ref.
Hedgehog (HH)	PTCH1, SMO, GLI	Vismodegib5E1RobotnikininGANT58GANT61HPI1-4GenisteinResveratrolCyclopamineMir-218SaridegibBMS-833923ErismodegibPF-0449913LY2940680	[27,28,83,84]
Notch/STAT3	Notch ligands (DLL), Notch receptors, JAK, ERK, STAT3	NapabucasinDemclzumab (anti-DLL4)TarextumabBBI-608	[28,76,85,86]
NANOG	NANOG, STAT3, Kinases	NapabucasinBBI-608BB1-503	[28,73,75,85]
Wnt/β-catenin	Wnt, β-catenin, LRP/FZD	Napabucasin BBI-608Vantictumab (anti-FZD)LGK974Foxy-5	[28,77,78,85,86]

GCSCs: Gastric cancer stem cells; HH: Hedgehog; NANOG: Nanog homeobox; STAT3: Signal transducer and activator of transcription 3; GLI: Glioma-associated oncogene; SMO: Smoothened; PTCH1: Patched homolog 1; ERK: Extracellular-signal-regulated kinase; JAK: Janus kinase; Wnt: Wingless/int1; LRP: Lipoprotein receptor-related proteins/low density lipoprotein receptor-related proteins; FZD: Frizzled receptors; DLL: Notch ligands.

Citation: Hsieh HL, Yu MC, Cheng LC, Yeh TS, Tsai MM. Molecular mechanism of therapeutic approaches for human gastric cancer stem cells. World J Stem Cells 2022; 14(1): 76-91
URL: https://www.wjgnet.com/1948-0210/full/v14/i1/76.htm
DOI: https://dx.doi.org/10.4252/wjsc.v14.i1.76